You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company has entered a bridge credit agreement for $2 billion and a revolving credit agreement for up to $1 billion.
The credit facility consists of a term loan of up to $20 million and a $10 million revolving line of credit, which will be used to purchase capital equipment and expand laboratory capacity.
The molecular diagnostics firm intends to pursue additional disease targets with its AlloMap technology.
The firm signed an agreement for a $15 million credit line and term loans totaling $6 million.
The firm has signed a $500 million credit facility, which it said will be used to provide working capital and fund general corporate purposes.
The firm said there is currently $240 million of borrowings outstanding under the credit facility.
Caliper extended the maturity date on its $25 million credit facility.
A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.
Undark looks into how coronavirus-related shutdowns are affecting field researchers.
In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.
NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.
